A medical nanodevice for non ventilatory oxygenation.

Now raising funding! (Watch the video in Spanish with English subtitles)

We are looking for private capital while in evaluation for the EUROSTARS European funding.

As for the Coronavirus rapid spread, we've decided to accelerate the GLOWIT R&D to obtain a functional molecule in about 6 weeks.

As GLOWIT may oxygenate bypassing the lungs, it may be used as a support treatment in Respiratory Failure which is the cause of death in Coronavirus infection. 

Contact us for more details email:

©2020 by Ceiimed. All the information cited here may be used only with permission.